191 related articles for article (PubMed ID: 15620693)
1. A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.
Ishida H; Togayachi A; Sakai T; Iwai T; Hiruma T; Sato T; Okubo R; Inaba N; Kudo T; Gotoh M; Shoda J; Tanaka N; Narimatsu H
FEBS Lett; 2005 Jan; 579(1):71-8. PubMed ID: 15620693
[TBL] [Abstract][Full Text] [Related]
2. Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells.
Seko A; Yamashita K
J Biol Chem; 2008 Nov; 283(48):33094-100. PubMed ID: 18826941
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.
Iwai T; Inaba N; Naundorf A; Zhang Y; Gotoh M; Iwasaki H; Kudo T; Togayachi A; Ishizuka Y; Nakanishi H; Narimatsu H
J Biol Chem; 2002 Apr; 277(15):12802-9. PubMed ID: 11821425
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer.
Liu Z; Shen L; Xu L; Sun X; Zhou J; Wu S
Mol Med Rep; 2011; 4(3):497-503. PubMed ID: 21468598
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel galactose beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8): the complex formation of beta3Gn-T2 and beta3Gn-T8 enhances enzymatic activity.
Seko A; Yamashita K
Glycobiology; 2005 Oct; 15(10):943-51. PubMed ID: 15917431
[TBL] [Abstract][Full Text] [Related]
6. Purification and cDNA cloning of UDP-GlcNAc:GlcNAcbeta1-3Galbeta1-4Glc(NAc)-R [GlcNAc to Gal]beta1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine.
Korekane H; Taguchi T; Sakamoto Y; Honke K; Dohmae N; Salminen H; Toivonen S; Helin J; Takio K; Renkonen O; Taniguchi N
Glycobiology; 2003 May; 13(5):387-400. PubMed ID: 12626393
[TBL] [Abstract][Full Text] [Related]
7. Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells.
Shen L; Liu Z; Tu Y; Xu L; Sun X; Wu S
Mol Biol Rep; 2011 Mar; 38(3):1541-50. PubMed ID: 20963502
[TBL] [Abstract][Full Text] [Related]
8. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
Iwai T; Kudo T; Kawamoto R; Kubota T; Togayachi A; Hiruma T; Okada T; Kawamoto T; Morozumi K; Narimatsu H
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4572-7. PubMed ID: 15755813
[TBL] [Abstract][Full Text] [Related]
9. beta1,3-N-Acetylglucosaminyltransferase-7 (beta3Gn-T7) acts efficiently on keratan sulfate-related glycans.
Seko A; Yamashita K
FEBS Lett; 2004 Jan; 556(1-3):216-20. PubMed ID: 14706853
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids.
Togayachi A; Akashima T; Ookubo R; Kudo T; Nishihara S; Iwasaki H; Natsume A; Mio H; Inokuchi J; Irimura T; Sasaki K; Narimatsu H
J Biol Chem; 2001 Jun; 276(25):22032-40. PubMed ID: 11283017
[TBL] [Abstract][Full Text] [Related]
11. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family.
Shiraishi N; Natsume A; Togayachi A; Endo T; Akashima T; Yamada Y; Imai N; Nakagawa S; Koizumi S; Sekine S; Narimatsu H; Sasaki K
J Biol Chem; 2001 Feb; 276(5):3498-507. PubMed ID: 11042166
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase.
Ujita M; McAuliffe J; Schwientek T; Almeida R; Hindsgaul O; Clausen H; Fukuda M
J Biol Chem; 1998 Dec; 273(52):34843-9. PubMed ID: 9857011
[TBL] [Abstract][Full Text] [Related]
15. A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases.
Zhou D; Dinter A; Gutiérrez Gallego R; Kamerling JP; Vliegenthart JF; Berger EG; Hennet T
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):406-11. PubMed ID: 9892646
[TBL] [Abstract][Full Text] [Related]
16. N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.
Ishimura H; Takahashi T; Nakagawa H; Nishimura S; Arai Y; Horikawa Y; Habuchi T; Miyoshi E; Kyan A; Hagisawa S; Ohyama C
Clin Cancer Res; 2006 Apr; 12(8):2506-11. PubMed ID: 16638859
[TBL] [Abstract][Full Text] [Related]
17. Regulation of I-branched poly-N-acetyllactosamine synthesis. Concerted actions by I-extension enzyme, I-branching enzyme, and beta1,4-galactosyltransferase I.
Ujita M; McAuliffe J; Suzuki M; Hindsgaul O; Clausen H; Fukuda MN; Fukuda M
J Biol Chem; 1999 Apr; 274(14):9296-304. PubMed ID: 10092606
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
Stanley P; Sundaram S; Tang J; Shi S
Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
[TBL] [Abstract][Full Text] [Related]
19. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of I-extension enzyme and beta1,4-galactosyltransferase I.
Ujita M; McAuliffe J; Hindsgaul O; Sasaki K; Fukuda MN; Fukuda M
J Biol Chem; 1999 Jun; 274(24):16717-26. PubMed ID: 10358011
[TBL] [Abstract][Full Text] [Related]
20. Developmental changes in the expression of glycogenes and the content of N-glycans in the mouse cerebral cortex.
Ishii A; Ikeda T; Hitoshi S; Fujimoto I; Torii T; Sakuma K; Nakakita S; Hase S; Ikenaka K
Glycobiology; 2007 Mar; 17(3):261-76. PubMed ID: 17172259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
